Hap Trading, LLC Beyond Spring Inc. Call Options Transaction History

Hap Trading, LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 12, 2022	SELL	$1.13 - $2.66 $19,435 - $45,752	-17,200 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$1.68 - $5.01 $7,560 - $22,545	-4,500 Reduced 20.74%	17,200 $4,000
Q4 2021 Feb 14, 2022	BUY	$4.02 - $16.84 $29,747 - $124,616	7,400 Added 51.75%	21,700 $15,000
Q3 2021 Nov 10, 2021	BUY	$9.26 - $31.31 $132,418 - $447,733	14,300 New	14,300 $12,000

5.55M

26K

2.4K

Ticker BYSI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,928,900
Market Cap $66.6M
Description
BeyondSpring Inc., a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immune-modulating microtubule-binding agent that has completed Phase III clinical trials for the prevention of chemotherapy-induced neutropenia; and...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.